Get started

Squeeze

$ROOT: TRENDING BULLISHLY. POTENTIAL SQUEEZE. 🚀🚀🚀Hello, everyone! We're seeing promising signals for $ROOT. If its price maintains above our key monthly indicator, we anticipate an uptrend. A very bullish trend will be confirmed when the daily indicator rises above the monthly one. Should this happen, we'll be on the lookout for the weekly indicator to follow suit. Our first price target (PT) is set at $76, with a strong move to $180 on the cards once the weekly crosses the monthly threshold. NASDAQ:ROOT has already made a massive move up, but this is only the start of something huge. However, if we see the hourly indicator fall below the monthly, this would need to be reassessed, as it could invalidate our current forecast. NFA! Good luck, everyone!
NASDAQ:ROOTLong
by SierrasTrades
6
MPW- About TImeMPW has been taking its swwwweeeetttt time overlapping and making lower lows This is absolutely related to that insane borrow fee and the shorting taking place But as with everything else, all things must come to an end :) Shorts are about to get wrecked for the next couple months most likely This should fly right along with the other stuff that squeezes from now throughout the summer I'll most likely end up making this part of my "Squeeze Me" series
NYSE:MPWLong
by Heartbeat_Trading
3
AMC - The Last BottomI've left this chart as big as possible so you can play around with it and see what I see as much as possible. We're bouncing off the $3.00 resistance level. There's one more resistance below us. $2.50. Anywhere much below that and we reach another new all-time low. Considering we're on a bear rally (no consistent higher-highs and higher-lows in months - greatly part to capitalizing on whatever bull rally available by offering shares to reduce debt) But considering AMC doesn't plan on offering new shares soon and the stock price is threatening to hit new all-time lows: the stock will have to decide whether this is the last bottom, or if the company is worth less than ever. I could see a retest of the the 2.50 range. After all, every single time we've hit a bottom, we've hit it again and then dropped even lower. There just needs one time where the stock can bounce fro an all-time low and go past "old lows". The price popped above the 200EMA on the 4-hour chart in May of last year, which led the stock to soar from 3.57 to 13.30 in a matter of a couple candles. I'm still waiting to see the price get pinched between the 200EMA on the daily chart (5.56 right now) and the bottom (2.40 right now). Earnings could be a catalyst. Some Trump decision could be a catalyst. Ken Griffin having a heart attack could be a catalyst (I don't wish any pain on anyone, but some deserve what's coming more than others). It doesn't matter. AMC is making leaps towards being a profitable business and the spring can only be wound so tight.
NYSE:AMCLong
by BakedSpud32
3
Potential bottom, turnaround; catalyst today?Buenos dias, This stock is crazy and I won't get into the details except at high level: The stock has, until recently, only had ~6.5m issued shares. Some dingus (or genius) cashed in their warrants for ~130m new shares, which sent the trade volume into a craze the past few days. Yesterday GCTK was the most traded stock and the most shorted stock on NASDAQ. Today the market cap of the company based on issued shares is approximately $ 20m. We do not know if the original owner of the warrants cashed out, is holding, or plans to cash out, although they received an outsized portion of shares for their warrants and could dump on the market, although I suspect the massive volume is related to their offloading of shares. Take a look at the larger chart - it has been dump city for years. So goes the life of a R&D company with no products. The company, however, has developed a novel diabetic monitor that is implantable, lasts 2-3 years, and gives real-time accurate data. This is an order of magnitude more efficient and capable than the best version of implantable devices today. The predict $ 1B in revenue early on after product launch. Today, they are presenting their latest trial data, presumably from their human subjects, at a major biotech conference at 12:30pm Eastern. This will be their first human-based data release. Taking a look at the past few days on the chart, despite a flood of new shares and despite a flood of shorting, the price has effectively triple bottomed at $0.11 and has withstood the great flood. I suspect that this is a new floor, and we will see a period of upward price movement, likely preceded by a large spike today due to speculators. I believe shorters are massively offside here, and there is opportunity to make a significant gain today and potentially over the next few years. Once they go to launch their product, it will be too late for speculators to make massive ROIs.
NASDAQ:GCTKLong
by nothximgood